Clinical Report: Two Dana-Farber Hematologists Receive Top Honors From ASH

Overview

The American Society of Hematology has awarded two Dana-Farber Cancer Institute hematologists for their significant contributions to the field. Dr. Benjamin L. Ebert received the Janet Rowley Basic Science Medal, while Dr. Scott A. Armstrong was honored with the E. Donnall Thomas Lecture and Prize.

Background

Recognition by the American Society of Hematology (ASH) highlights the importance of research and innovation in hematology. Awards such as the Janet Rowley Basic Science Medal and the E. Donnall Thomas Lecture and Prize acknowledge the contributions of researchers in advancing treatment and understanding of blood disorders.

Data Highlights

No numerical or trial data available in the source material.

Key Findings

• Dr. Benjamin L. Ebert was awarded the Janet Rowley Basic Science Medal for his contributions to hematology research.
• Dr. Ebert's research includes discoveries related to blood cancers and pre-cancers, impacting patient care.
• Dr. Scott A. Armstrong received the E. Donnall Thomas Lecture and Prize for his work on leukemia.
• Dr. Armstrong's research has led to new therapeutic strategies for various leukemia subtypes.
• Both awards will be presented at the 2026 ASH Annual Meeting in New Orleans.

Clinical Implications

The honors received by Dr. Ebert and Dr. Armstrong reflect their contributions to the field of hematology.

Conclusion

The recognition of these two distinguished hematologists highlights their achievements in the field of hematology.

Related Resources & Content

1. Dana-Farber, Source, 2023 -- More Than 145 Dana-Farber Affiliated Faculty Named as 2026 Top Doctors™ in Boston Magazine
2. The ASCO Post, Source, 2018 -- ASH Honors Freda K. Stevenson, DPhil, and Brunangelo Falini, MD, With 2018 Henry M. Stratton Medal
3. The ASCO Post, Source, 2019 -- American Association for the Advancement of Science Honors 2018 Elected Fellows
4. The ASCO Post, Source, 2020 -- Edward J. Benz, Jr, MD, Receives 2020 ASH Award for Leadership in Promoting Diversity
5. Acute Myeloid Leukemia Guidelines - Hematology.org, Source, 2025 -- Clinical Practice Guidelines
6. FDA, Source, 2024 -- FDA approves revumenib for relapsed or refractory acute leukemia with a KMT2A translocation
7. NCCN Guidelines® Insights, Source, 2025 -- Myelodysplastic Syndromes, Version 2.2025
8. American Heart Association, Source, 2023 -- Clonal Hematopoiesis and Its Cardiovascular Implications
9. Acute Myeloid Leukemia Guidelines - Hematology.org
10. FDA approves revumenib for relapsed or refractory acute leukemia with a KMT2A translocation | FDA
11. NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025 - PubMed
12. Hub - Clonal Hematopoiesis and Its Cardiovascular Implications - Professional Heart Daily | American Heart Association